Literature DB >> 23735145

Cause-specific excess mortality among dialysis patients: comparison with the general population in Japan.

Minako Wakasugi1, Junichiro James Kazama, Suguru Yamamoto, Kazuko Kawamura, Ichiei Narita.   

Abstract

Despite significant therapeutic advances, mortality of dialysis patients remains unacceptably high. The aim of this study is to compare mortality and its causes in dialysis patients with those in the general Japanese population. We used data for 2008 and 2009 from the Japanese Society for Dialysis Therapy registry and a national Vital Statistics survey. Cardiovascular mortality was defined as death attributed to heart failure, cerebrovascular disorders, myocardial infarction, hyperkalemia/sudden death, and pulmonary thromboembolism. Non-cardiovascular mortality was defined as death attributed to infection, malignancies, cachexia/uremia, chronic hepatitis/cirrhosis, ileus, bleeding, suicide/refusal of treatment, and miscellaneous. We calculated standardized mortality ratios and age-adjusted mortality differences between dialysis patients and the general population for all-cause, cardiovascular versus non-cardiovascular, and cause-specific mortality. During the 2-year study period, there were 2,284,272 and 51,432 deaths out of 126 million people and 273,237 dialysis patients, respectively. The standardized mortality ratio for all-cause mortality was 4.6 (95% confidence interval, 4.6-4.7) for the dialysis patients compared to the general population. Age-adjusted mortality differences for cardiovascular and non-cardiovascular disease were 33.1 and 30.0 per 1000 person-years, respectively. The standardized mortality rate ratios were significant for all cause-specific mortality rates except accidental death. Our study revealed that excess mortality in dialysis patients compared to the general population in Japan is large, and differs according to age and cause of death. Cause-specific mortality studies should be planned to improve life expectancies of dialysis patients.
© 2012 The Authors. Therapeutic Apheresis and Dialysis © 2012 International Society for Apheresis.

Entities:  

Mesh:

Year:  2012        PMID: 23735145     DOI: 10.1111/j.1744-9987.2012.01144.x

Source DB:  PubMed          Journal:  Ther Apher Dial        ISSN: 1744-9979            Impact factor:   1.762


  16 in total

1.  Elucidating variations in outcomes among older end-stage renal disease patients on hemodialysis in Fukuoka Prefecture, Japan.

Authors:  Aziz Jamal; Akira Babazono; Yunfei Li; Takako Fujita; Shinichiro Yoshida; Sung A Kim
Journal:  PLoS One       Date:  2021-05-25       Impact factor: 3.240

2.  Premature mortality due to nephrotic syndrome and the trend in nephrotic syndrome mortality in Japan, 1995-2014.

Authors:  Minako Wakasugi; Junichiro James Kazama; Ichiei Narita
Journal:  Clin Exp Nephrol       Date:  2017-05-06       Impact factor: 2.801

3.  Emotional disturbance assessed by the Self-Rating Depression Scale test is associated with mortality among Japanese Hemodialysis patients.

Authors:  Sakumi Kazama; Junichiro James Kazama; Minako Wakasugi; Yumi Ito; Ichiei Narita; Motoko Tanaka; Fumi Horiguchi; Koichi Tanigawa
Journal:  Fukushima J Med Sci       Date:  2018-02-03

Review 4.  Noncardiovascular mortality in CKD: an epidemiological perspective.

Authors:  Dinanda J de Jager; Marc G Vervloet; Friedo W Dekker
Journal:  Nat Rev Nephrol       Date:  2014-02-04       Impact factor: 28.314

5.  Fruit and Vegetable Intake and Mortality in Adults undergoing Maintenance Hemodialysis.

Authors:  Valeria M Saglimbene; Germaine Wong; Marinella Ruospo; Suetonia C Palmer; Vanessa Garcia-Larsen; Patrizia Natale; Armando Teixeira-Pinto; Katrina L Campbell; Juan-Jesus Carrero; Peter Stenvinkel; Letizia Gargano; Angelo M Murgo; David W Johnson; Marcello Tonelli; Rubén Gelfman; Eduardo Celia; Tevfik Ecder; Amparo G Bernat; Domingo Del Castillo; Delia Timofte; Marietta Török; Anna Bednarek-Skublewska; Jan Duława; Paul Stroumza; Susanne Hoischen; Martin Hansis; Elisabeth Fabricius; Paolo Felaco; Charlotta Wollheim; Jörgen Hegbrant; Jonathan C Craig; Giovanni F M Strippoli
Journal:  Clin J Am Soc Nephrol       Date:  2019-01-31       Impact factor: 8.237

6.  Comparisons of postoperative outcomes after breast cancer surgery in patients with and without renal replacement therapy: a matched-pair cohort study using a Japanese nationwide inpatient database.

Authors:  Takaaki Konishi; Michimasa Fujiogi; Nobuaki Michihata; Kojiro Morita; Hiroki Matsui; Kiyohide Fushimi; Masahiko Tanabe; Yasuyuki Seto; Hideo Yasunaga
Journal:  Breast Cancer       Date:  2021-04-10       Impact factor: 4.239

7.  Excess mortality among patients on dialysis: Comparison with the general population in Korea.

Authors:  Hyungyun Choi; Myounghee Kim; Hyunwook Kim; Jung Pyo Lee; Jeonghwan Lee; Jung Tak Park; Kyoung Hoon Kim; Hyeong Sik Ahn; Hoo Jae Hann; Dong-Ryeol Ryu
Journal:  Kidney Res Clin Pract       Date:  2014-05-28

8.  The cardiothoracic ratio and all-cause and cardiovascular disease mortality in patients undergoing maintenance hemodialysis: results of the MBD-5D study.

Authors:  Hiroaki Ogata; Junji Kumasawa; Shingo Fukuma; Masahide Mizobuchi; Eriko Kinugasa; Masafumi Fukagawa; Shunichi Fukuhara; Tadao Akizawa
Journal:  Clin Exp Nephrol       Date:  2017-05-15       Impact factor: 2.801

9.  Serum Creatinine Modifies Associations between Body Mass Index and Mortality and Morbidity in Prevalent Hemodialysis Patients.

Authors:  Yukitoshi Sakao; Toshiyuki Ojima; Hideo Yasuda; Seiji Hashimoto; Takeshi Hasegawa; Kunitoshi Iseki; Yoshiharu Tsubakihara; Akihiko Kato
Journal:  PLoS One       Date:  2016-03-01       Impact factor: 3.240

10.  Effects of angiotensin-converting enzyme inhibitors or angiotensin receptor blockers on all-cause mortality, cardiovascular death, and cardiovascular events among peritoneal dialysis patients: A protocol for systematic review.

Authors:  Surapon Nochaiwong; Chidchanok Ruengorn; Pajaree Mongkhon; Kednapa Thavorn; Ratanaporn Awiphan; Kajohnsak Noppakun; Surachet Vongsanim; Wilaiwan Chongruksut; Brian Hutton; Manish M Sood; Greg A Knoll
Journal:  Medicine (Baltimore)       Date:  2020-04       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.